Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.


TSXV:NSCI - Post by User

Comment by Baconatoron Jul 29, 2021 5:23pm
98 Views
Post# 33629599

RE:RE:Updated price points

RE:RE:Updated price points

My numbers, please weigh in with your thoughts as well:

Currently fully diluted at 72,000,000 outstanding as per the AGM slide from Luke. 

Assuming maximum over allotment of 15% (who wouldn't want a peice of this company at that price).  Total shares issued would be approximately 7,700,000 at $1.20 for gross proceeds of $9,240,000. Which, I would hope, is enough for their plans.

There is an option for another $5,000,000 at these terms but I doubt that will take place unless they really need the money for some reason (multiple acquisitions). So I assume they'll stop at the 7.7 stated above.


The warrants would come in at 1,900,000 at @ 1.70 in 24 months. Sweet deal, which will surpress the share price likely in the short term.  


72 current plus the 7.7 puts them at a very rough 80 million outstanding.

80 million at $1.20 values the company at 95.2 million.

StoneGate had a valuation of 84.4 million to 196.8 million. With a mid point of 140.6 million. 

So even with the dilution today, we are still at the low end of the valuation and in a much better position financially to execute the business plan more rapidly. 


 


 

 

<< Previous
Bullboard Posts
Next >>